Document is current
Any future updates will be listed below
-
Authors
Nakajima, Atsushi
Unno, Aki
Ota, Takumi
Shoji, Ayako
Uenishi, Tatsuhiro
Igarashi, Ataru
-
Funding
Funding for this research was provided by:
EA Pharma Co., Ltd.
Mochida Pharmaceutical Co., Ltd.
- License Information
-
More Information
Article History
Received: 14 April 2025
Accepted: 15 September 2025
First Online: 21 October 2025
Declarations
:
: This trial was registered with the UMIN Clinical Trials Registry (registration number: UMIN000055903).
: Not applicable.
: AN has served as a medical adviser to EA Pharma Co., Ltd., and Mochida Pharmaceutical Co., Ltd.; has received lecture fees from EA Pharma Co., Ltd., Astellas Pharma Inc., and Viatris Inc.; and has received a research grant from EA Pharma Co., Ltd. AU is an employee of EA Pharma Co., Ltd. TO is an employee of Mochida Pharmaceutical Co., Ltd. AS was and TU is a manager of Healthcare Consulting Inc., which was commissioned to perform this work by EA Pharma Co., Ltd. and Mochida Pharmaceutical Co., Ltd. AI reports honoraria from EA Pharma Co., Ltd., Mochida Pharmaceutical Co., Ltd., and Astellas Pharma Inc.
